Leukapheresis Market worth $100 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148 Browse in-depth TOC on "Leukapheresis Market" 230 - Tables80 - Figures295 - Pages Leukapheresis Market Scope:   In this report, the overall leukapheresis market is divided into the leukapheresis products market and the Leukopaks Market. The leukapheresis products...

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148

Browse in-depth TOC on "Leukapheresis Market"

230 - Tables
80 - Figures
295 - Pages

Leukapheresis Market Scope:

 

In this report, the overall leukapheresis market is divided into the leukapheresis products market and the Leukopaks Market. The leukapheresis products Market is classified into segments including type, application, end user, and region, and the leukopaks Market is classified into segments such as type, indication, end user, and region.

The disposables segment accounted for the larger share of the leukapheresis products market.

By type, the leukapheresis products market can be segmented into devices and disposables. The disposables segment occupied a larger share of the leukapheresis products market in 2022. The disposables used in leukapheresis procedures are products used to access blood vessels and store blood components, replacement fluids, and anticoagulants to prevent blood from clotting in the process. Disposables are used for both automated blood collection and therapeutic leukapheresis. They include apheresis catheters, needle sets, centrifuge bowls, tubing sets/pipeline systems, collection bags, and various solutions such as saline, anticoagulants, media, columns, filters, and cell separation kits.

The mobilized leukopaks segment dominated the leukopaks market based on type.

By type, the leukopaks market is categorized into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. The mobilized leukopaks segment dominated the leukopaks market in 2022. Mobilized leukopaks are mainly used in preclinical and clinical research in a variety of fields, including cancer immunotherapy, cell therapy, and regenerative medicine. Charles River Laboratories (US), Discovery Life Sciences (US), StemExpress (US), BioIVT (US), and Caltag Medsystems (UK) are some of the major players offering mobilized leukopaks for research and clinical applications.

North American region dominated the Leukapheresis market with the largest market share.

The Leukapheresis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America reported the largest share of the Leukapheresis market in 2022. The incidence and prevalence of leukemia are increasing in North America, due to factors such as environmental pollution, exposure to radiation, and unhealthy lifestyle habits. This is driving the demand for leukapheresis products, which are used to treat leukemia.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148

Leukapheresis Market Dynamics:

Drivers:

1.  Increased demand for leukopaks in clinical research

Restraints:

1.  Complications associated with therapeutic leukapheresis

Opportunities:

1.  Gaps in current leukapheresis technologies

Challenges:

1.  Blood transfusion safety in developing countries

Key Market Players:

Key players in the leukapheresis products market include Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany). Some prominent players in the leukopaks market are Discovery Life Sciences (US), StemExpress, LLC (US), Charles River Laboratories International, Inc. (US), Caltag Medsystems Limited (UK), Lonza Group AG (Switzerland), and ZenBio (US). These companies adopted strategies such as product launches, business expansions, agreements, partnerships, and acquisitions to strengthen their presence in the Leukapheresis market.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=20283148

Leukapheresis Market Advantages:

Medical Progress: The leukapheresis market represents a significant stride toward the future of medicine, fostering innovation and progress in healthcare through its specialized cell collection capabilities.

Recent Developments:

Related Reports:

Plasma Fractionation Market - Global Forecasts to 2027

Continuous Renal Replacement Therapy Market - Global Forecasts to 2026

Corporate Wellness Solutions Market - Global Forecasts to 2026

US Therapeutic Plasma Exchange Market - Global Forecasts to 2025

Apheresis Market - Global Forecasts to 2025

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/leukapheresis-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/leukapheresis.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/leukapheresis-market-worth-100-million--marketsandmarkets-301914641.html